Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.470
-0.100-2.19%
Volume:12.85M
Turnover:57.71M
Market Cap:28.09B
PE:5.95
High:4.600
Open:4.600
Low:4.470
Close:4.570
52wk High:6.336
52wk Low:4.211
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:1.20
T/O Rate:0.20%
Dividend:0.22
Dividend Rate:4.87%
EPS(LYR):0.751
ROE:8.32%
ROA:2.64%
PB:0.46
PE(LYR):5.95
PS:0.09

Loading ...

Global Bio-Chem unit wins Shenzhou Bio-tech order for 1,270 tonnes coenzyme Q10 mycelium

Reuters
·
May 08

China Resources Pharma unit CR Pharmaceutical Commercial posts Q1 net profit RMB 455.29 million

Reuters
·
Apr 30

China Resources Pharma unit CR Pharmaceutical Commercial issues RMB 1.4 billion bonds at 1.65%

Reuters
·
Apr 28

CR Pharmaceutical Commercial Completes RMB1.40 Billion Second-Tranche 2026 Bond Offering

Bulletin Express
·
Apr 28

CHINARES PHARMA Subsidiary Completes RMB 1.4 Billion Corporate Bond Issuance

Stock News
·
Apr 28

华润医药2025业绩稳健增长,聚焦研发及业务布局优化

Bulletin Express
·
Apr 28

CHINARES PHARMA Releases 2025 ESG Report: Revenue Up 4.6%, Carbon Intensity Down 20% from 2020

Bulletin Express
·
Apr 28

China Resources Pharma publishes 2025 sustainability report

Reuters
·
Apr 28

China Resources Pharmaceutical publishes 2025 annual report

Reuters
·
Apr 28

China Resources Pharma Shares Slump Over 5% Following Mixed Q1 Results From Subsidiaries

Stock News
·
Apr 27

Dong-E-E-Jiao's Profit Jumps 7% in Q1, Revenue Up 5.5%

MT Newswires Live
·
Apr 27

Stock Track | CHINARES PHARMA Plummets 5.02% Intraday on Subsidiary's Profit and Revenue Decline

Stock Track
·
Apr 27

CR Double-Crane's Profit, Revenue Fall in Q1

MT Newswires Live
·
Apr 27

CR Boya Bio-pharmaceutical Q1 2026: Revenue Down 40.1% YoY, Net Profit Drops 78.4%

Bulletin Express
·
Apr 24

China Resources Pharmaceutical - Cr Boya Bio-Pharmaceutical Qtrly Unaudited Revenue RMB 321.1 Mln, Net Profit RMB 30.0 Mln

THOMSON REUTERS
·
Apr 24

China Resources Pharma subsidiary CR Boya Bio Q1 net profit falls to RMB 30 million

Reuters
·
Apr 24

CHINARES PHARMA's Unit Kpc Pharmaceuticals Swings to Q1 Loss

Stock News
·
Apr 24

China Resources Pharmaceutical Group Ltd - Kpc Q1 Net Loss at RMB 144.8 Mln

THOMSON REUTERS
·
Apr 24

China Resources Pharmaceutical Group Ltd - Kpc Q1 Revenue at RMB 836.2 Mln

THOMSON REUTERS
·
Apr 24

CR Sanjiu Q1 2026: Revenue Jumps 18.6% but Net Profit Slips 9.1%; Cash Outflow Weighs on China Resources Pharmaceutical Subsidiary

Bulletin Express
·
Apr 24